T1	PROC 53 87	Estudio en seres humanos fase 1/2a
T2	CHEM 93 125	anticuerpo monoclonal BMS-986218
#1	AnnotatorNotes T2	C4525955; Anti-CTLA4 Monoclonal Antibody BMS-986218; Amino Acid, Peptide, or Protein · Immunologic Factor · Pharmacologic Substance
T3	PROC 129 140	monoterapia
#2	AnnotatorNotes T3	C4763675; Single Agent Therapy; Therapeutic or Preventive Procedure
T4	CHEM 162 171	nivolumab
#3	AnnotatorNotes T4	C3657270; nivolumab; Amino Acid, Peptide, or Protein · Immunologic Factor · Pharmacologic Substance
T5	DISO 175 190	tumores sólidos
#4	AnnotatorNotes T5	C0280100; Solid Neoplasm; Neoplastic Process
T6	DISO 223 238	Tumores sólidos
#5	AnnotatorNotes T6	C0280100; Solid Neoplasm; Neoplastic Process
T7	DISO 380 392	tumor sólido
#6	AnnotatorNotes T7	C0280100; Solid Neoplasm; Neoplastic Process
T8	DISO 459 477	enfermedad medible
#7	AnnotatorNotes T8	C1513041; Measurable Disease; Disease or Syndrome
T9	PROC 500 510	evaluación
#8	AnnotatorNotes T9	C1261322; Evaluation procedure; Health Care Activity
T10	ANAT 574 582	próstata
#9	AnnotatorNotes T10	C0033572; Prostate; Body Part, Organ, or Organ Component | C1278980; Entire prostate; Body Part, Organ, or Organ Component
T11	DISO 619 644	lesión de tejidos blandos
#10	AnnotatorNotes T11	C0410013; Soft tissue lesion; Pathologic Function
T12	ANAT 629 644	tejidos blandos
#11	AnnotatorNotes T12	C0225317; soft tissue; Tissue
T13	PROC 660 667	biopsia
#12	AnnotatorNotes T13	C0005558; Biopsy; Diagnostic Procedure
T14	PROC 738 765	prueba de embarazo en orina
#13	AnnotatorNotes T14	C0430056; Urine pregnancy test; Laboratory Procedure
T15	PROC 811 822	tratamiento
#14	AnnotatorNotes T15	C0087111; Therapeutic procedure; Therapeutic or Preventive Procedure
T16	DISO 938 966	neoplasias primarias del SNC
#15	AnnotatorNotes T16	C0751620; Central Nervous System Neoplasms, Primary; Neoplastic Process
T17	ANAT 963 966	SNC
#16	AnnotatorNotes T17	C1269563; Entire central nervous system; Body System | C3714787; Central Nervous System; Body System
T18	DISO 969 1001	tumores con metástasis en el SNC
T19	ANAT 998 1001	SNC
#17	AnnotatorNotes T19	C1269563; Entire central nervous system; Body System | C3714787; Central Nervous System; Body System
T20	DISO 1028 1038	enfermedad
#18	AnnotatorNotes T20	C0012634; Disease; Disease or Syndrome
T21	DISO 411 422	metastásico
#19	AnnotatorNotes T21	C0027627; Neoplasm Metastasis; Neoplastic Process | C4255448; Metastasis; Pathologic Function
T22	ANAT 721 726	suero
#20	AnnotatorNotes T22	C0229671; Serum; Body Substance | C0588987; Serum product; Body Substance
T23	ANAT 760 765	orina
#21	AnnotatorNotes T23	C0042036; Urine; Body Substance
T24	ANAT 874 879	pecho
#22	AnnotatorNotes T24	C0006141; Breast; Body Part, Organ, or Organ Component | C1268990; Entire breast; Body Part, Organ, or Organ Component
T25	Date 13 17	2017
T26	LIVB 64 77	seres humanos
#23	AnnotatorNotes T26	C0086418; Homo sapiens; Human
T27	Age 307 323	al menos 18 años
T29	LIVB 675 697	mujeres en edad fértil
#24	AnnotatorNotes T29	C4324275; Woman of childbearing potential; Population Group
T32	Duration 776 788	las 24 horas
T33	LIVB 842 849	mujeres
#25	AnnotatorNotes T33	C0043210; Woman; Population Group
T34	Neg_cue 850 852	no
T35	PHYS 865 879	dando el pecho
#26	AnnotatorNotes T35	C0006147; Breast Feeding; Organism Function
T36	PHYS 881 892	amamantando
#27	AnnotatorNotes T36	C0006147; Breast Feeding; Organism Function
T37	LIVB 924 933	pacientes
#28	AnnotatorNotes T37	C0030705; Patients; Patient or Disabled Group
T38	Neg_cue 1046 1055	excluidos
T39	PHYS 748 756	embarazo
#29	AnnotatorNotes T39	C0032961; Pregnancy; Organism Function
T40	Age 686 697	edad fértil
T30	Neg_cue 727 735	negativo
T28	PROC 336 373	confirmación histológica o citológica
#30	AnnotatorNotes T28	C1305671; Cytology procedure; Laboratory Procedure + C0344441; Histology Procedure; Laboratory Procedure
A1	Population_data T29 Age
A2	Assertion T39 Negated
A3	Assertion T35 Negated
A4	Assertion T36 Negated
A5	Assertion T16 Negated
A6	Assertion T18 Negated
A8	Assertion T37 Negated
#31	AnnotatorNotes T18	C0686377; CNS metastases; Neoplastic Process
T31	Neg_cue 441 443	no
T41	Quantifier_or_Qualifier 444 453	resecable
A7	Assertion T41 Negated
#32	AnnotatorNotes T41	C1514888; Resectable; Qualitative Concept
T42	LIVB 281 294	participantes
#33	AnnotatorNotes T42	C4554048; Study Participant; Population Group
R1	Experiences Arg1:T26 Arg2:T2	
R2	Used_for Arg1:T2 Arg2:T3	
R3	Combined_with Arg1:T2 Arg2:T4	
R4	Experiences Arg1:T26 Arg2:T4	
R5	Experiences Arg1:T26 Arg2:T5	
T43	Quantifier_or_Qualifier 191 199	avanzado
R6	Has_Quantifier_or_Qualifier Arg1:T5 Arg2:T43	
#34	AnnotatorNotes T43	C0205179; Advanced phase; Qualitative Concept | C1522484; metastatic qualifier; Functional Concept
T44	Quantifier_or_Qualifier 239 248	avanzados
#35	AnnotatorNotes T44	C0205179; Advanced phase; Qualitative Concept | C1522484; metastatic qualifier; Functional Concept
R7	Has_Quantifier_or_Qualifier Arg1:T6 Arg2:T44	
T45	Quantifier_or_Qualifier 401 409	avanzado
#36	AnnotatorNotes T45	C0205179; Advanced phase; Qualitative Concept | C1522484; metastatic qualifier; Functional Concept
R8	Has_Quantifier_or_Qualifier Arg1:T7 Arg2:T45	
R9	Has_Age Arg1:T42 Arg2:T27	
R10	Negation Arg1:T31 Arg2:T41	
R11	Has_Quantifier_or_Qualifier Arg1:T7 Arg2:T41	
R12	Before Arg1:T7 Arg2:T21	
T46	Observation 424 434	recurrente
#37	AnnotatorNotes T46	C0679254; Disease recurrence; Finding
R13	Has_Quantifier_or_Qualifier Arg1:T7 Arg2:T46	
T47	CONC 511 522	RECIST v1.1
#38	AnnotatorNotes T47	C1709926; Response Evaluation Criteria in Solid Tumors; Intellectual Product
R14	Used_for Arg1:T47 Arg2:T9	
R19	Location_of Arg1:T10 Arg2:T7	
T48	CONC 562 566	PCWG
#39	AnnotatorNotes T48	C4288533; PCWG Scher Prostate Cancer 2008 Oncology Response Criteria; Intellectual Product (?)
R20	Used_for Arg1:T48 Arg2:T9	
R21	Location_of Arg1:T12 Arg2:T11	
R22	Location_of Arg1:T12 Arg2:T13	
R23	Has_Age Arg1:T29 Arg2:T40	
R24	Location_of Arg1:T22 Arg2:T14	
R25	Location_of Arg1:T23 Arg2:T14	
R26	Experiences Arg1:T29 Arg2:T14	
R27	Negation Arg1:T30 Arg2:T39	
R28	Overlap Arg1:T14 Arg2:T32	
R29	Before Arg1:T14 Arg2:T15	
R30	Experiences Arg1:T29 Arg2:T15	
R31	Experiences Arg1:T33 Arg2:T35	
R32	Experiences Arg1:T33 Arg2:T36	
R33	Location_of Arg1:T24 Arg2:T35	
R34	Negation Arg1:T34 Arg2:T35	
R35	Negation Arg1:T34 Arg2:T36	
R36	Experiences Arg1:T37 Arg2:T16	
R37	Location_of Arg1:T17 Arg2:T16	
R38	Location_of Arg1:T19 Arg2:T18	
R39	Experiences Arg1:T37 Arg2:T18	
R40	Negation Arg1:T38 Arg2:T18	
R41	Negation Arg1:T38 Arg2:T16	
R42	Experiences Arg1:T37 Arg2:T20	
R15	Location_of Arg1:T10 Arg2:T8	
R16	Experiences Arg1:T29 Arg2:T39	
R17	Location_of Arg1:T24 Arg2:T36	
R18	Location_of Arg1:T19 Arg2:T20	
R43	Location_of Arg1:T17 Arg2:T20	
A9	Experiencer T37 Patient
A10	Experiencer T33 Patient
A11	Experiencer T29 Patient
A12	Experiencer T42 Patient
A13	Experiencer T26 Patient
T49	Quantifier_or_Qualifier 606 618	al menos una
R44	Has_Quantifier_or_Qualifier Arg1:T11 Arg2:T49	
